IgA is necessary and sufficient to prevent norovirus infection in mice
Authors:
- Arya B. ÖktenAÖArya B. Ökten
- Renata B. FillerRFRenata B. Filler
- Justin L. KungJKJustin L. Kung
- Zhenhao FangZFZhenhao Fang
- Brieyanna C. McWilliamsBMBrieyanna C. McWilliams
- Michael S. KegelMKMichael S. Kegel
- Madeleine C. MankowskiMMMadeleine C. Mankowski
- Ashwin N. SkellyASAshwin N. Skelly
- Jilian R. MelamedJMJilian R. Melamed
- Timothy J. NiceTNTimothy J. Nice
- 24 June 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (855) , eaeb4878
Abstract
Human norovirus is the leading cause of viral gastroenteritis, yet effective vaccines and therapeutics remain elusive. Using murine norovirus as a model, we found that mucosal immunoglobulin A (IgA) is both necessary and sufficient for protection against infection, whereas CD8 + T cells are dispensable. Robust intestinal IgA production requires at least 4 weeks of enteric infection, consistent with kinetics of human norovirus RNA clearance. Systemic vaccination elicits high titers of neutralizing serum IgG but fails to prevent enteric norovirus infection, phenocopying a recent human norovirus vaccine failure. In contrast, prophylactic delivery of dimeric anti-norovirus IgA via mRNA lipid nanoparticles confers sterilizing immunity. Together, these findings define a critical role for mucosal IgA in norovirus protection and identify IgA-based treatments as a therapeutic approach for human norovirus.Keywords
Funding Information
- National Institutes of Health (R01AI183155)
- National Institutes of Health (R01AI148467)
- National Institutes of Health (1DP2AI184637)
- National Institutes of Health (R01AI168016)
- National Institutes of Health (R37AR40072)
- National Institutes of Health (R01AI168016)
- National Institutes of Health (1R01AI189484-01)
- National Institutes of Health (1R01AI189484-01)
- Burroughs Wellcome Fund
- Penn Measey Scholars in Molecular Medicine Fellowship
- Cancer Research Institute (CRI4964)
- Colton Center for Autoimmunity at Yale
This publication has 83 references indexed in Scilit:
- Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic driftCell Reports, 2025
- Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and SolutionsAdvanced Materials, 2024
- Antigen spacing on protein nanoparticles influences antibody responses to vaccinationCell Reports, 2023
- Tuft-cell-intrinsic and -extrinsic mediators of norovirus tropism regulate viral immunityCell Reports, 2022
- Recent advances in understanding norovirus pathogenesisJournal of Medical Virology, 2016
- Human and Non-Human Primate Intestinal FcRn Expression and Immunoglobulin G TranscytosisPharmaceutical Research, 2013
- Selective IgA DeficiencyJournal of Clinical Immunology, 2010
- Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to NorovirusesJournal of Medical Virology, 2006
- Generation of recombinant Norovirus-like particles (VLP) in the human endothelial kidney cell line 293TArchives of Virology, 2005
- Viral gastroenteritis induced by the Hawaii agentThe American Journal of Medicine, 1975